rss
J Clin Pathol 2004;57:667-669 doi:10.1136/jcp.2003.013979
  • Case report

Atypical haemolytic uraemic syndrome as a complication of induction chemotherapy for acute lymphoblastic leukaemia

  1. D Chandra,
  2. S Lawson,
  3. P Ramani
  1. Birmingham Children’s Hospital, Steelhouse Lane, Birmingham B4 6NH, UK
  1. Correspondence to:
 Dr D Chandra
 Department of Paediatric Haematology, Birmingham Children’s Hospital, Steelhouse Lane, Birmingham, B4 6NH, UK; deepak.chandrabch.nhs.uk
  • Accepted 28 November 2003

Abstract

This report describes a case of fatal haemolytic uraemic syndrome (HUS) developing in a child with acute lymphoblastic leukaemia (ALL) during induction chemotherapy. The aetiology in this case is uncertain but it may have resulted from treatment with L-asparaginase or vincristine. The possibility of HUS during induction chemotherapy for ALL should be considered early on in the treatment regimen, if clinical signs and symptoms suggest this diagnosis, so that appropriate treatment can be instituted.

Footnotes

    Register for free content


    Free trial
    Individuals may register for a free 60 day online trial to all content.

    Free archive
    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they ar